Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences

BRISBANE, Calif., March 6, 2019 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in the following healthcare investor conferences in March:

• Cowen 39^th Annual Health Care Conference
  Presentation Date: Tuesday, March 12^th at 8:40 a.m. Eastern Time
  Location: Boston, MA
• Barclays 2019 Global Healthcare Conference
  Presentation Date: Thursday, March 14^th at 8:00 a.m. Eastern Time
  Location: Miami, FL
• ARM 7^th Annual Cell & Gene Investor Day
  Presentation Date: Thursday, March 21^st at 2:45 p.m. Eastern Time
  Location: New York, NY

The presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will be archived on the Sangamo website for two weeks after the events.

About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic medicines with the potential to transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit www.sangamo.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-participation-at-upcoming-investor-conferences-300807944.html

SOURCE Sangamo Therapeutics, Inc.